心脏衰竭风险,再入院和死亡率预测中的预测性分析:一篇评论
Qisthi A Hidayaturrohman1,2, Eisuke Hanada3
1Graduate School of Science and Engineering, Saga University, Saga, JPN.
Cureus
|December 19, 2024
概括
预测分析,包括机器学习,显示了早期心力衰竭检测和减少医院再入院的前景. 对于临床使用,需要进一步的研究.
科学领域:
- 心脏病学 心脏病学
- 医疗信息学 医疗信息学
- 数据科学数据科学数据科学
背景情况:
- 心力衰竭是全球主要的死亡原因.
- 高昂的治疗费用和再接收率给医疗保健系统带来了压力.
- 早期预测可以改善患者的治疗结果和医院资源管理.
研究的目的:
- 审查最近的心力衰竭风险,再入院和死亡率的预测分析模型.
- 确定用于心力衰竭预测的常见建模技术和数据源.
- 评估预测分析在临床实践中的潜力.
主要方法:
- 对心力衰竭预测分析研究的文献综述.
- 分析常见的机器学习算法 (例如随机森林,物流回归,神经网络,XGBoost).
- 检查数据来源,包括电子健康记录 (结构化和非结构化数据) 和预处理技术 (归算,特征选择).
主要成果:
- 预测分析模型显示了早期心力衰竭诊断的潜力.
- 模型在分层再接收风险和预测死亡率方面表现有前途.
- 机器学习技术越来越多地应用于心力衰竭预测.
结论:
- 预测分析,特别是机器学习,为改善心力衰竭结果提供了巨大的潜力.
- 进一步严格的研究和基准测试是必要的临床采用.
- 从电子健康记录中提升数据的利用可以促进心力衰竭的管理.
更多相关视频
06:55Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
14.4K
07:31Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
Published on: May 15, 2020
7.0K
相关概念视频
Hazard Rate
88
The hazard rate, also known as the hazard function or failure rate, is a statistical measure used to describe the instantaneous rate at which an event occurs, given that the event has not yet happened. From a probabilistic perspective, it represents the likelihood that a subject will experience the event in a very small time interval, conditional on surviving up to the beginning of that interval. In terms of frequency, the hazard rate can be viewed as the ratio of the number of events to the...
88
Cancer Survival Analysis
328
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
328
Comparing the Survival Analysis of Two or More Groups
149
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
149
Pulse rhythm
759
Pulse rhythm refers to the pattern of pulsations within specific intervals, offering valuable insights into the regularity or irregularity of the heart's beats as observed through the pattern of pulsation within specific intervals. A regular pulse exhibits a consistent heart rate with uniform waveforms and pulsation force, variations of which can be classified as normal, weak, or bounding.
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
759
Kaplan-Meier Approach
94
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
94
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
382
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
382
